SLC16A3 and breast carcinoma: Notably, although SLC16A1 mRNA levels showed no association with breast cancer survival (Figure 10—figure supplement 1B–G), high SLC16A3 mRNA levels were significantly associated with—or showed tendency toward—poor survival in all breast cancer molecular subtypes (Figure 10—figure supplement 2B,C and E–G) except for luminal A (Figure 10—figure supplement 2D).